End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
56,800 KRW | +1.07% | +8.60% | -30.65% |
May. 03 | Volpara to Delist After Court Approves Acquisition by Lunit | MT |
Apr. 16 | Lunit Wins Shareholder Approval for Volpara Health Takeover | MT |
Valuation
Fiscal Period: December | 2022 | 2023 | 2024 | 2025 |
---|---|---|---|---|
Capitalization 1 | 364,383 | 2,332,210 | 1,633,557 | - |
Enterprise Value (EV) 2 | 364.4 | 2,332 | 1,464 | 1,454 |
P/E ratio | -7.95 x | - | - | - |
Yield | - | - | - | - |
Capitalization / Revenue | - | 93 x | 30.5 x | 16.9 x |
EV / Revenue | - | 93 x | 27.3 x | 15.1 x |
EV / EBITDA | - | -60.7 x | -111 x | 61.7 x |
EV / FCF | - | - | - | - |
FCF Yield | - | - | - | - |
Price to Book | - | - | 7.63 x | 7.21 x |
Nbr of stocks (in thousands) | 24,455 | 28,476 | 28,760 | - |
Reference price 3 | 14,900 | 81,900 | 56,800 | 56,800 |
Announcement Date | 3/21/23 | 2/15/24 | - | - |
Income Statement Evolution (Annual data)
Fiscal Period: December | 2022 | 2023 | 2024 | 2025 |
---|---|---|---|---|
Net sales 1 | - | 25.08 | 53.55 | 96.38 |
EBITDA 1 | - | -38.44 | -13.15 | 23.55 |
EBIT 1 | - | -42.18 | -15.22 | 22.9 |
Operating Margin | - | -168.19% | -28.42% | 23.77% |
Earnings before Tax (EBT) | - | - | - | - |
Net income 1 | -39.12 | -36.75 | -15.73 | 12.2 |
Net margin | - | -146.52% | -29.38% | 12.66% |
EPS | -1,874 | - | - | - |
Free Cash Flow | - | - | - | - |
FCF margin | - | - | - | - |
FCF Conversion (EBITDA) | - | - | - | - |
FCF Conversion (Net income) | - | - | - | - |
Dividend per Share 2 | - | - | - | - |
Announcement Date | 3/21/23 | 2/15/24 | - | - |
Income Statement Evolution (Quarterly data)
Fiscal Period: December | 2023 Q1 | 2023 Q2 |
---|---|---|
Net sales 1 | - | 5.445 |
EBITDA | - | - |
EBIT 1 | - | -10.04 |
Operating Margin | - | -184.46% |
Earnings before Tax (EBT) 1 | - | -9.996 |
Net income 1 | -2.086 | -9.996 |
Net margin | - | -183.56% |
EPS | -85.00 | - |
Dividend per Share | - | - |
Announcement Date | 5/10/23 | 8/11/23 |
Balance Sheet Analysis
Fiscal Period: December | 2022 | 2023 | 2024 | 2025 |
---|---|---|---|---|
Net Debt 1 | - | - | - | - |
Net Cash position 1 | - | - | 170 | 180 |
Leverage (Debt/EBITDA) | - | - | - | - |
Free Cash Flow | - | - | - | - |
ROE (net income / shareholders' equity) | - | -24.2% | -7.1% | 5.55% |
ROA (Net income/ Total Assets) | - | - | - | - |
Assets 1 | - | - | - | - |
Book Value Per Share 2 | - | - | 7,448 | 7,873 |
Cash Flow per Share 2 | - | - | -476.0 | 448.0 |
Capex | - | - | - | - |
Capex / Sales | - | - | - | - |
Announcement Date | 3/21/23 | 2/15/24 | - | - |
EPS & Dividend
Year-on-year evolution of the PER
Year-on-year evolution of the Yield
Change in Enterprise Value/EBITDA
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-30.65% | 1.21B | |
+5.70% | 32.88B | |
+18.46% | 7.84B | |
+22.71% | 3.95B | |
-17.95% | 3.11B | |
-19.93% | 1.38B | |
+4.36% | 933M | |
-34.81% | 911M | |
-26.60% | 829M | |
-15.56% | 728M |
- Stock Market
- Equities
- A328130 Stock
- Financials Lunit Inc.